OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Proteomics is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics	23
How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?	22
24th Human Proteome Organization World Congress; Results from the Early Career Researcher Manuscript Competition announcement	21
Proteomic profiling and network biology of colorectal cancer liver metastasis	19
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease	16
Oncoproteomic profiling of AML: moving beyond genomics	15
Omics and rare diseases: challenges, applications, and future perspectives	15
Protein therapeutics in sports drug testing: past, present and future	14
Positional proteomics: is the technology ready to study clinical cohorts?	14
The method developer’s guide to oligonucleotide design	14
Mapping the human brain proteome: opportunities, challenges, and clinical potential	13
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage	11
Utilizing databases for astrocyte secretome research	11
A computational method for the prediction and functional analysis of potential Mycobacterium tuberculosis adhesin-related proteins	11
Proteomic tools to study phosphorylation of intrinsically disordered proteins	10
Deciphering mitochondrial metabolic vulnerabilities in ovarian clear cell carcinoma with mass spectrometry-based clinical proteomics	9
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection	9
Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets	9
Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers	9
Mass spectrometry (MS)-based proteomics and the sulfome: clinical potential	9
Proteomic profiling of cerebrospinal fluid reveals pathophysiology changes and diversity of treatment response in pediatric Streptococcus pneumoniae meningitis	8
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology	8
A Galaxy of informatics resources for MS-based proteomics	7
Rebellion of the deregulated regulators: What is the clinical relevance of studying intrinsically disordered proteins?	7
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research	7

Recent advances in mass spectrometry for the detection of doping	7
Proteomic interrogation of the human olfactory system: the road ahead	6
Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease	6
T cell population size control by coronin 1 uncovered: from a spot identified by two-dimensional gel electrophoresis to quantitative proteomics	6
Analyzing the glial proteome in Alzheimer’s disease	6
Evaluation of a ‘plug and play’ nanoflow liquid chromatography system for MS-based proteomic characterization of clinical FFPE specimens	5
Extracellular vesicle proteomics in brain solid tumors: future strategy for personalized medicine	5
Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control	5
How to maximize power for differential expression analysis in discovery omics through experimental design	5
Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease	5
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease	5
The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance	5
The evolution of analytical techniques for multiplex analysis of protein biomarkers	5
How glycomic studies can impact on prostate cancer	5
Glycosylation in cancer as a source of biomarkers	5
Interaction and regulation of the mitochondrial proteome – in health and disease	5
Tackling reproducibility: lessons for the proteomics community	5
Salivary metabolomics in early detection of oral squamous cell carcinoma – a meta-analysis	5
Advances in the clinical use of metaproteomics	5
VDAC1: at the crossroads of cancer signalling and metabolism	5
Proteomic profiling of oral squamous cell carcinoma tissues reveals altered immune-related proteins: implications for personalized therapy	5